Skip to content

Natera, Inc. NTRA Americas, excluding U.S. — Total revenues

Other geography segments

Europe Middle East India And Africa
$24.48M+2.5%
Europe, Middle East, India, Africa
$6.43M+6.2%
Asia Pacific and Other
$2.22M

Similar metrics at other companies

NCR Voyix logo
VYXAmericas (excluding United States) — Total Revenue
$38M-11.6%
Pacific Biosciences of California logo
PACBAmericas — Total Revenue
$16.69M+2.3%
Calix logo
CALXAmericas Ex U.S. — Total revenues
$6.28M+14.9%
NCR Atleos logo
NATLAmericas (excluding U.S.) — Total Revenue
$115M+4.5%
Open Text logo
OTEXAmericas — Total revenues
$702.17M-2.5%
10x Genomics, Inc. logo
TXGAmericas (excluding United States) — Revenue
$3.41M-9.2%

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$37.51B+59.8%
Enterprise value$36.66B+61.8%
P/S15×+3.1×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natera, Inc.'s americas, excluding u.s. — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Natera, Inc.'s americas, excluding U.S. — total revenues?
Natera, Inc. (NTRA) reported americas, excluding U.S. — total revenues of $2.4M in Q1 2026.
What does americas, excluding U.S. — total revenues mean?
This metric represents the total revenue generated from diagnostic testing services and research collaborations within the Americas region, specifically excluding the United States. It captures the company's market penetration and commercial success in international markets across North and South America. Tracking this figure helps investors assess the geographic diversification of the business and the scalability of its molecular diagnostic offerings outside of its primary domestic market.